Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Peptidream Inc (4587 JP)
Watchlist
27
Analysis
Health Care
•
Japan
PeptiDream Inc. is a biopharmaceutical company that researches and develops peptide therapeutics to improve the life of patients.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Peptidream Inc
•
01 May 2024 22:55
Peptidream (4587 JP): Steadily Riding the Next Wave of Drug Discovery
Peptidream got nod for first human trial for radiopharma targeting renal cell carcinoma. Expanded peptide discovery collaboration with Novartis...
Tina Banerjee
Follow
257 Views
Share
bullish
•
Peptidream Inc
•
09 Sep 2023 00:54
Peptidream (4587 JP): Solid Revenue Growth Continued in 1H23; 2023 Guidance Remains Unchanged
In 1H23, revenue jumped 88% YoY, and both the operating and net losses have narrowed compared with 1H22. 2023 guidance calls for a 12% YoY revenue...
Tina Banerjee
Follow
487 Views
Share
bullish
•
Peptidream Inc
•
17 May 2023 18:20
Peptidream (4587 JP): 1Q23 Result- Radiopharma Drove Sales; Losses Narrowed; Guidance Reiterated
Peptidream recorded ¥5B revenue in 1Q23. While base business revenue jumped 133% YoY, acquired radiopharma contributed ¥4B revenue. Compared with...
Tina Banerjee
Follow
216 Views
Share
bullish
•
Peptidream Inc
•
03 Jan 2023 23:52
Peptidream (4587 JP): Rising Drug Discovery Collaborations To Drive Growth; New Revenue Stream Added
In long-term, Peptidream targets ¥100B revenue from ¥9.4B in 2021. While base business is poised for steady growth via expansion of collaboration...
Tina Banerjee
Follow
427 Views
Share
bullish
•
Ono Pharmaceutical
•
28 Dec 2022 00:00
Ono Pharmaceutical (4528 JP): Key Drugs On High Growth Trajectory; Pipeline Expands Beyond Opdivo
Driven by indication expansion, Ono expects Opdivo sales to reach ¥155B in FY23, up 38% y/y. The company is developing clinical pipeline beyond...
Tina Banerjee
Follow
793 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.1
x